Cargando…

Antitumor activity of chLpMab‐2, a human–mouse chimeric cancer‐specific antihuman podoplanin antibody, via antibody‐dependent cellular cytotoxicity

Human podoplanin (hPDPN), a platelet aggregation‐inducing transmembrane glycoprotein, is expressed in different types of tumors, and it binds to C‐type lectin‐like receptor 2 (CLEC‐2). The overexpression of hPDPN is involved in invasion and metastasis. Anti‐hPDPN monoclonal antibodies (mAbs) such as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaneko, Mika K., Yamada, Shinji, Nakamura, Takuro, Abe, Shinji, Nishioka, Yasuhiko, Kunita, Akiko, Fukayama, Masashi, Fujii, Yuki, Ogasawara, Satoshi, Kato, Yukinari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387135/ https://www.ncbi.nlm.nih.gov/pubmed/28332312 http://dx.doi.org/10.1002/cam4.1049

Ejemplares similares

The chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity
por: Kato, Yukinari, et al.
Publicado: (2015)

PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry
por: Ogasawara, Satoshi, et al.
Publicado: (2017)

Characterization of Monoclonal Antibody LpMab-3 Recognizing Sialylated Glycopeptide of Podoplanin
por: Oki, Hiroharu, et al.
Publicado: (2015)

LpMab-12 Established by CasMab Technology Specifically Detects Sialylated O-Glycan on Thr52 of Platelet Aggregation-Stimulating Domain of Human Podoplanin
por: Kato, Yukinari, et al.
Publicado: (2016)

A Humanized and Defucosylated Antibody against Podoplanin (humLpMab-23-f) Exerts Antitumor Activities in Human Lung Cancer and Glioblastoma Xenograft Models
por: Suzuki, Hiroyuki, et al.
Publicado: (2023)

Establishment of P38Bf, a Core-Fucose-Deficient Mouse-Canine Chimeric Antibody Against Dog Podoplanin
por: Kato, Yukinari, et al.
Publicado: (2018)

Development and characterization of anti‐glycopeptide monoclonal antibodies against human podoplanin, using glycan‐deficient cell lines generated by CRISPR/Cas9 and TALEN
por: Kaneko, Mika K., et al.
Publicado: (2017)

Elucidation of Critical Epitope of Anti-Rat Podoplanin Monoclonal Antibody PMab-2
por: Furusawa, Yoshikazu, et al.
Publicado: (2018)

Epitope mapping of anti-mouse podoplanin monoclonal antibody PMab-1
por: Yamada, Shinji, et al.
Publicado: (2018)

PMab-219: A monoclonal antibody for the immunohistochemical analysis of horse podoplanin
por: Furusawa, Yoshikazu, et al.
Publicado: (2019)

Antitumor effect of novel anti‐podoplanin antibody NZ‐12 against malignant pleural mesothelioma in an orthotopic xenograft model
por: Abe, Shinji, et al.
Publicado: (2016)

LpMab-23-recognizing cancer-type podoplanin is a novel predictor for a poor prognosis of early stage tongue cancer
por: Miyazaki, Akihiro, et al.
Publicado: (2018)

The mouse–canine chimeric anti-dog podoplanin antibody P38B exerts antitumor activity in mouse xenograft models
por: Kato, Yukinari, et al.
Publicado: (2018)

PMab-235: A monoclonal antibody for immunohistochemical analysis against goat podoplanin
por: Furusawa, Yoshikazu, et al.
Publicado: (2019)

Development of an anti-bear podoplanin monoclonal antibody PMab-247 for immunohistochemical analysis
por: Furusawa, Yoshikazu, et al.
Publicado: (2019)

Establishment of a monoclonal antibody PMab-233 for immunohistochemical analysis against Tasmanian devil podoplanin
por: Furusawa, Yoshikazu, et al.
Publicado: (2019)

Detection of high CD44 expression in oral cancers using the novel monoclonal antibody, C(44)Mab-5
por: Yamada, Shinji, et al.
Publicado: (2018)

Establishment of a monoclonal antibody PMab-225 against alpaca podoplanin for immunohistochemical analyses
por: Kato, Yukinari, et al.
Publicado: (2019)

Antibody–Drug Conjugates Using Mouse–Canine Chimeric Anti-Dog Podoplanin Antibody Exerts Antitumor Activity in a Mouse Xenograft Model
por: Kato, Yukinari, et al.
Publicado: (2020)

A Cancer-specific Monoclonal Antibody Recognizes the Aberrantly Glycosylated Podoplanin
por: Kato, Yukinari, et al.
Publicado: (2014)

Detection of high PD-L1 expression in oral cancers by a novel monoclonal antibody L(1)Mab-4
por: Yamada, Shinji, et al.
Publicado: (2018)

Immunohistochemical Examination of Novel Rat Monoclonal Antibodies against Mouse and Human Podoplanin
por: Kaji, Chiaki, et al.
Publicado: (2012)

Epitope Analysis of an Anti-Whale Podoplanin Monoclonal Antibody, PMab-237, Using Flow Cytometry
por: Sayama, Yusuke, et al.
Publicado: (2020)

Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma
por: Itai, Shunsuke, et al.
Publicado: (2018)

H(2)Mab-77 is a Sensitive and Specific Anti-HER2 Monoclonal Antibody Against Breast Cancer
por: Itai, Shunsuke, et al.
Publicado: (2017)

Determination of critical epitope of PcMab-47 against human podocalyxin
por: Itai, Shunsuke, et al.
Publicado: (2018)

Epitope mapping of an anti-diacylglycerol kinase delta monoclonal antibody DdMab-1
por: Sano, Masato, et al.
Publicado: (2020)

Roles of Podoplanin in Malignant Progression of Tumor
por: Suzuki, Hiroyuki, et al.
Publicado: (2022)

Preclinical Evaluation of Podoplanin-Targeted Alpha-Radioimmunotherapy with the Novel Antibody NZ-16 for Malignant Mesothelioma
por: Sudo, Hitomi, et al.
Publicado: (2021)

Therapeutic efficacy evaluation of radioimmunotherapy with (90)Y‐labeled anti‐podoplanin antibody NZ‐12 for mesothelioma
por: Sudo, Hitomi, et al.
Publicado: (2019)

Establishment of C(20)Mab-11, a novel anti-CD20 monoclonal antibody, for the detection of B cells
por: Furusawa, Yoshikazu, et al.
Publicado: (2020)

Establishment and Epitope Mapping of Anti-Diacylglycerol Kinase α Monoclonal Antibody DaMab-8 for Immunohistochemical Analyses
por: Sano, Masato, et al.
Publicado: (2020)

Novel circulating tumor cell-detection chip combining conventional podoplanin and EGFR antibodies for all histological malignant pleural mesothelioma
por: Kanayama, Masatoshi, et al.
Publicado: (2021)

Development and characterization of TrMab-6, a novel anti-TROP2 monoclonal antibody for antigen detection in breast cancer
por: Sayama, Yusuke, et al.
Publicado: (2021)

Generation and evaluation of a chimeric antibody against coxsackievirus and adenovirus receptor for cancer therapy
por: Sakamoto, Shuichi, et al.
Publicado: (2019)

Isocitrate dehydrogenase 2 mutation is a frequent event in osteosarcoma detected by a multi-specific monoclonal antibody MsMab-1
por: Liu, Xing, et al.
Publicado: (2013)

Increased alloreactive and autoreactive antihuman leucocyte antigen antibodies associated with systemic lupus erythematosus and rheumatoid arthritis
por: Jackman, Rachael P, et al.
Publicado: (2018)

De novo protein sequencing, humanization and in vitro effects of an antihuman CD34 mouse monoclonal antibody
por: Fan, Chia-Yu, et al.
Publicado: (2016)

Elucidation of the critical epitope of an anti-EGFR monoclonal antibody EMab-134
por: Kaneko, Mika K., et al.
Publicado: (2018)

Establishment of a novel anti-TROP2 monoclonal antibody TrMab-29 for immunohistochemical analysis
por: Sayama, Yusuke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ksoava241f5u2se2bltusa81pr